Durham-based restor3D closes $70 million in funding

Durham-based restor3d this week announced it has received $70 million in financing by closing $55 million in Series A funding by private investors and securing $15 million in debt financing. 

The designer and manufacturer of 3D-printed orthopedic implants will use the investments to release new patient-specific 3D-printed implants, invest in new 3D technology, expand its implementation of software and 3D automation tools, and provide medical education training for surgeons and its sales team. 

Summers Value Partners and existing investors led the $55 million Series funding round. Trinity Capital led the debt financing. restor3d logo snip

“This fundraising round is a testament to the confidence our investors have in restor3d’s vision and potential," said Kurt Jacobus, chief executive officer of restor3d, in a statement. “With this capital, we can accelerate our efforts to transform orthopedic care through 3D-printed personalized implants. We are eager to maximize our impact on patient outcomes and continue to advance orthopedic care.”

The new round of financing will allow the company to continue focusing on personalized orthopedic solutions for patients. One such solution is a porous press-fit knee created using its 3D technology to print the tibial and femoral components.

Founded in 2017, the company expanded its footprint in RTP late last year when it relocated into a more than 50,000-square-foot facility in Research Triangle Park. The space is divided between office and manufacturing space. 

Mindy Hamlin, NCBiotech Writer
scroll back to top of page